Medtronic has submitted its first pre-market approval (PMA) module to the U.S. Food and Drug Administration (FDA) for the IN.PACT Admiral drug-eluting balloon designed to treat atherosclerotic lesions in the superficial femoral artery ...
Tags: Medtronic, Admiral Drug-Eluting
Medtronic has completed patient enrollment in controlled, multicenter, prospective IN.PACT SFA II clinical trial of its IN.PACT Admiral drug-eluting balloon device for treating patients with peripheral artery disease in the superficial ...
Tags: drug, Medtronic, eluting balloon study
Medtronic has completed enrolling patients in a clinical trial of its Amphirion drug-eluting balloon, designed to treat critical limb ischemia. The CE-marked Amphirion drug-eluting balloon features proprietary FreePac proprietary ...
Tags: Medtronic, clinical trial, limb ischemia, Amphirion drug-eluting balloon
Cardionovum has started in vivo testing of its paclitaxel-coated Restore drug-eluting balloon (DEB) to evaluate drug-in-tissue concentration. The Restore DEB, including EXPRESS drug-release platform, is designed for the treatment of ...
Tags: drug-eluting balloon, clinical product, clinical trial
The European Union has granted CE mark certification to Blue Medical Devices' non compliant, high pressure drug eluting balloon (DEB). The new Protege NC device incorporates medication added to non compliant PTCA balloon, designed to ...
Tags: drug eluting balloon, post-dilatate stents, Blue Medical